Primary Malignant Liver Neoplasm — Trials

Primary Malignant Liver Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,486 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 807
Recruiting: 471
Ph III recruiting: 42
Growth YoY: +1.5%
Industry share: 21%
Top sponsor: Sun Yat-sen University
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (402)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05441475	A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients	enrolling by invitation	Phase 2	118	Abbisko Therapeutics Co, LtdINDUSTRY	1	Feb 25, 2026	clinicaltrials
NCT05171335	Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients	enrolling by invitation	Phase 2	50	The Methodist Hospital Research InstituteOTHER	1	Sep 21, 2022